| Literature DB >> 25313962 |
Jiwen Yang1, Lee-Hsueh Hung2, Thomas Licht1, Sawa Kostin1, Mario Looso1, Ekaterina Khrameeva3, Albrecht Bindereif2, Andre Schneider4, Thomas Braun5.
Abstract
Cell-type-specific splicing generates numerous alternatively spliced transcripts playing important roles for organ development and homeostasis, but only a few tissue-specific splicing factors have been identified. We found that RBM24 governs a large number of muscle-specific splicing events that are critically involved in cardiac and skeletal muscle development and disease. Targeted inactivation of RBM24 in mice disrupted cardiac development and impaired sarcomerogenesis in striated muscles. In vitro splicing assays revealed that recombinant RBM24 is sufficient to promote muscle-specific exon inclusion in nuclear extracts of nonmuscle cells. Furthermore, we demonstrate that binding of RBM24 to an intronic splicing enhancer (ISE) is essential and sufficient to overcome repression of exon inclusion by an exonic splicing silencer (ESS) containing PTB and hnRNP A1/A2 binding sites. Introduction of ESS and ISE converted a constitutive exon into an RMB24-dependent alternative exon. We reason that RBM24 is a major regulator of alternative splicing in striated muscles.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25313962 DOI: 10.1016/j.devcel.2014.08.025
Source DB: PubMed Journal: Dev Cell ISSN: 1534-5807 Impact factor: 12.270